Eighty-five days shy of October, the month when respiratory virus season typically begins in the U.S., the CDC and FDA have already made several key announcements about what clinicians can expect for the 2024-2025 round of vaccines for the infections that dominate during this time of year: influenza, respiratory syncytial virus and COVID-19.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
